Hypoxia causes IL-8 secretion, Charcot Leyden crystal formation, and suppression of corticosteroid-induced apoptosis in human eosinophils
File(s)
Author(s)
Type
Journal Article
Abstract
Background
Inflamed environments are typically hypercellular, rich in pro‐inflammatory cytokines, and profoundly hypoxic. While the effects of hypoxia on neutrophil longevity and function have been widely studied, little is known about the consequences of this stimulus on eosinophils.
Objective
We sought to investigate the effects of hypoxia on several key aspects of eosinophil biology, namely secretion, survival, and their sensitivity to glucocorticosteroids (GCS), agents that normally induce eosinophil apoptosis.
Methods
Eosinophils derived from patients with asthma/atopy or healthy controls were incubated under normoxia and hypoxia, with or without glucocorticoids. Activation was measured by flow cytometry, ELISA of cultured supernatants, and F‐actin staining; apoptosis and efferocytosis by morphology and flow cytometry; and GCS efficacy by apoptosis assays and qPCR.
Results
Hypoxic incubation (3 kPa) caused (i) stabilization of HIF‐2α and up‐regulation of hypoxia‐regulated genes including BNIP3 (BCL2/adenovirus E1B 19‐kDa protein‐interacting protein 3) and GLUT1 (glucose transporter 1); (ii) secretion of pre‐formed IL‐8, and Charcot Leyden crystal (CLC) formation, which was most evident in eosinophils derived from atopic and asthmatic donors; (iii) enhanced F‐actin formation; (iv) marked prolongation of eosinophil lifespan (via a NF‐κB and Class I PI3‐kinase‐dependent mechanism); and (v) complete abrogation of the normal pro‐apoptotic effect of dexamethasone and fluticasone furoate. This latter effect was evident despite preservation of GCS‐mediated gene transactivation under hypoxia.
Conclusion and Clinical Relevance
These data indicate that hypoxia promotes an eosinophil pro‐inflammatory phenotype by enhancing eosinophil secretory function, delaying constitutive apoptosis, and importantly, antagonizing the normal pro‐apoptotic effect of GCS. As eosinophils typically accumulate at sites that are relatively hypoxic, particularly during periods of inflammation, these findings may have important implications to understanding the behaviour of these cells in vivo.
Inflamed environments are typically hypercellular, rich in pro‐inflammatory cytokines, and profoundly hypoxic. While the effects of hypoxia on neutrophil longevity and function have been widely studied, little is known about the consequences of this stimulus on eosinophils.
Objective
We sought to investigate the effects of hypoxia on several key aspects of eosinophil biology, namely secretion, survival, and their sensitivity to glucocorticosteroids (GCS), agents that normally induce eosinophil apoptosis.
Methods
Eosinophils derived from patients with asthma/atopy or healthy controls were incubated under normoxia and hypoxia, with or without glucocorticoids. Activation was measured by flow cytometry, ELISA of cultured supernatants, and F‐actin staining; apoptosis and efferocytosis by morphology and flow cytometry; and GCS efficacy by apoptosis assays and qPCR.
Results
Hypoxic incubation (3 kPa) caused (i) stabilization of HIF‐2α and up‐regulation of hypoxia‐regulated genes including BNIP3 (BCL2/adenovirus E1B 19‐kDa protein‐interacting protein 3) and GLUT1 (glucose transporter 1); (ii) secretion of pre‐formed IL‐8, and Charcot Leyden crystal (CLC) formation, which was most evident in eosinophils derived from atopic and asthmatic donors; (iii) enhanced F‐actin formation; (iv) marked prolongation of eosinophil lifespan (via a NF‐κB and Class I PI3‐kinase‐dependent mechanism); and (v) complete abrogation of the normal pro‐apoptotic effect of dexamethasone and fluticasone furoate. This latter effect was evident despite preservation of GCS‐mediated gene transactivation under hypoxia.
Conclusion and Clinical Relevance
These data indicate that hypoxia promotes an eosinophil pro‐inflammatory phenotype by enhancing eosinophil secretory function, delaying constitutive apoptosis, and importantly, antagonizing the normal pro‐apoptotic effect of GCS. As eosinophils typically accumulate at sites that are relatively hypoxic, particularly during periods of inflammation, these findings may have important implications to understanding the behaviour of these cells in vivo.
Date Issued
2017-06-01
Date Acceptance
2016-11-27
Citation
Clinical and Experimental Allergy, 2017, 47 (6), pp.770-784
ISSN
0954-7894
Publisher
Wiley
Start Page
770
End Page
784
Journal / Book Title
Clinical and Experimental Allergy
Volume
47
Issue
6
Copyright Statement
© 2016 John Wiley & Sons Ltd. This is the accepted version of the following article: L. M. Porter, A. S. Cowburn, N. Farahi, J. Deighton, S. N. Farrow, C. A. Fiddler, J. K. Juss, A. M. Condliffe and E. R. Chilvers, Clinical & Experimental Allergy, 2017 (47) 770–784., which has been published in final form at https://dx.doi.org/10.1111/cea.12877
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000402653100007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
apoptosis
corticosteroids
eosinophils
hypoxia
IL-8
PLATELET-ACTIVATING-FACTOR
HUMAN NEUTROPHILS
AIRWAY INFLAMMATION
ENDOTHELIAL-CELLS
INTERFERON-GAMMA
POTENTIAL ROLE
IN-VITRO
INTERLEUKIN-8
ASTHMA
EXPRESSION
Publication Status
Published
Date Publish Online
2017-02-03